Dana Meier

Dana Meier currently serves as Director, Field Medical Lead Oncology (West) at Sumitomo Pharma America, Inc., a position held since May 2025. Prior to this role, Dana Meier was with Menarini Stemline from September 2022 to May 2025, serving as Head of Medical Excellence & Operations and Senior Director of Medical Excellence for Solid Tumor and Hematology. An extensive career at Novartis spanned from January 2007 to September 2022, featuring roles such as Director of Value Evidence & Strategy in Oncology and Regional Director of MSLs in Respiratory. Additional experience includes positions at the University of Minnesota as an Adjunct Professor, and various roles in pharmaceutical companies including Prime Therapeutics, Wyeth, and CVS/Caremark. Dana Meier earned a Doctor of Pharmacy (PharmD) degree from Creighton University.